[
    {
        "id": "4704885",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-07-18T12:40:29-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4704885-abbott-laboratories-abt-q2-2024-earnings-call-transcript"
        }
    },
    {
        "id": "4684269",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-04-17T12:05:26-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4684269-abbott-laboratories-abt-q1-2024-earnings-call-transcript"
        }
    },
    {
        "id": "4664715",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-01-24T12:48:03-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories (ABT) Q4 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4664715-abbott-laboratories-abt-q4-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4662007",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-01-09T15:28:03-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories (ABT) 42nd Annual J.P. Morgan Healthcare Conference Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4662007-abbott-laboratories-abt-42nd-annual-j-p-morgan-healthcare-conference-call-transcript"
        }
    },
    {
        "id": "4641572",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-10-18T12:14:10-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories (ABT) Q3 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4641572-abbott-laboratories-abt-q3-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4618478",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-07-20T12:59:08-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories (ABT) Q2 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4618478-abbott-laboratories-abt-q2-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4595034",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-04-19T12:56:06-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories (ABT) Q1 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4595034-abbott-laboratories-abt-q1-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4572315",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-01-25T13:00:26-05:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4572315-abbott-laboratories-abt-q4-2022-earnings-call-transcript"
        }
    },
    {
        "id": "4569066",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-01-10T14:04:06-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories (ABT) 41st Annual J.P. Morgan Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4569066-abbott-laboratories-abt-41st-annual-j-p-morgan-healthcare-conference-transcript"
        }
    },
    {
        "id": "4558527",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2022-11-16T14:14:07-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems, Inc. 2023 Q1 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4558527-cardiovascular-systems-inc-2023-q1-results-earnings-call-presentation"
        }
    },
    {
        "id": "4553704",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-11-05T13:58:03-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems, Inc. (CSII) Q1 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4553704-cardiovascular-systems-inc-csii-q1-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4547541",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-10-19T13:23:05-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories (ABT) Q3 2022 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4547541-abbott-laboratories-abt-q3-2022-earnings-call-transcript"
        }
    },
    {
        "id": "4524458",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-07-20T10:21:05-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories (ABT) CEO Robert Ford on Q2 2022 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4524458-abbott-laboratories-abt-ceo-robert-ford-on-q2-2022-results-earnings-call-transcript"
        }
    },
    {
        "id": "4508733",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-05-08T07:42:34-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems, Inc. (CSII) CEO Scott Ward on Q3 2022 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4508733-cardiovascular-systems-inc-csii-ceo-scott-ward-on-q3-2022-results-earnings-call-transcript"
        }
    },
    {
        "id": "4507162",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2022-05-05T03:02:01-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems, Inc. 2022 Q3 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4507162-cardiovascular-systems-inc-2022-q3-results-earnings-call-presentation"
        }
    },
    {
        "id": "4502422",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-04-20T12:16:08-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories' (ABT) CEO Robert Ford on Q1 2022 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4502422-abbott-laboratories-abt-ceo-robert-ford-on-q1-2022-results-earnings-call-transcript"
        }
    },
    {
        "id": "4502394",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2022-04-20T10:50:20-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories 2022 Q1 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4502394-abbott-laboratories-2022-q1-results-earnings-call-presentation"
        }
    },
    {
        "id": "4484083",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-02-03T14:23:06-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems, Inc. (CSII) CEO Scott Ward on Q2 2022 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4484083-cardiovascular-systems-inc-csii-ceo-scott-ward-on-q2-2022-results-earnings-call-transcript"
        }
    },
    {
        "id": "4483997",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2022-02-03T13:21:47-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems, Inc. 2022 Q2 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4483997-cardiovascular-systems-inc-2022-q2-results-earnings-call-presentation"
        }
    },
    {
        "id": "4481794",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-01-26T12:36:06-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories (ABT) CEO Robert Ford on Q4 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4481794-abbott-laboratories-abt-ceo-robert-ford-on-q4-2021-results-earnings-call-transcript"
        }
    },
    {
        "id": "4479032",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-01-11T11:45:18-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories (ABT) CEO Robert Ford Presents at JPMorgan 40th Annual Healthcare Brokers Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4479032-abbott-laboratories-abt-ceo-robert-ford-presents-jpmorgan-40th-annual-healthcare-brokers"
        }
    },
    {
        "id": "4468412",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-11-11T10:57:22-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems, Inc. 2022 Q1 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4468412-cardiovascular-systems-inc-2022-q1-results-earnings-call-presentation"
        }
    },
    {
        "id": "4467572",
        "type": "transcript",
        "attributes": {
            "publishOn": "2021-11-09T15:55:30-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems, Inc. (CSII) CEO Scott Ward on Q1 2022 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4467572-cardiovascular-systems-inc-csii-ceo-scott-ward-on-q1-2022-results-earnings-call-transcript"
        }
    },
    {
        "id": "4460885",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-10-20T15:04:15-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories 2021 Q3 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4460885-abbott-laboratories-2021-q3-results-earnings-call-presentation"
        }
    },
    {
        "id": "4460855",
        "type": "transcript",
        "attributes": {
            "publishOn": "2021-10-20T13:11:19-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories' (ABT) CEO Robert Ford on Q3 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4460855-abbott-laboratories-abt-ceo-robert-ford-on-q3-2021-results-earnings-call-transcript"
        }
    },
    {
        "id": "4450720",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-08-19T15:28:08-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems (CSII) Presents At 6 th Annual Needham Virtual Med Tech & Diagnostics 1X1 Conference - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4450720-cardiovascular-systems-csii-presents-6-th-annual-needham-virtual-med-tech-and-diagnostics-1x1"
        }
    },
    {
        "id": "4449642",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-08-16T06:40:17-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems (CSII) Presents At 41st Annual Canaccord Genuity Growth Virtual Conference - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4449642-cardiovascular-systems-csii-presents-41st-annual-canaccord-genuity-growth-virtual-conference"
        }
    },
    {
        "id": "4446776",
        "type": "transcript",
        "attributes": {
            "publishOn": "2021-08-08T08:41:18-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems' (CSII) CEO Scott Ward on Q4 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4446776-cardiovascular-systems-csii-ceo-scott-ward-on-q4-2021-results-earnings-call-transcript"
        }
    },
    {
        "id": "4445258",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-08-05T04:30:11-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems, Inc. 2021 Q2 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4445258-cardiovascular-systems-inc-2021-q2-results-earnings-call-presentation"
        }
    },
    {
        "id": "4440671",
        "type": "transcript",
        "attributes": {
            "publishOn": "2021-07-22T12:23:03-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories (ABT) CEO Robert Ford on Q2 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4440671-abbott-laboratories-abt-ceo-robert-ford-on-q2-2021-results-earnings-call-transcript"
        }
    },
    {
        "id": "4428319",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-05-13T14:16:13-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems, Inc. 2021 Q3 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4428319-cardiovascular-systems-inc-2021-q3-results-earnings-call-presentation"
        }
    },
    {
        "id": "4426230",
        "type": "transcript",
        "attributes": {
            "publishOn": "2021-05-09T01:53:07-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems, Inc. (CSII) CEO Scott Ward on Q3 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4426230-cardiovascular-systems-inc-csii-ceo-scott-ward-on-q3-2021-results-earnings-call-transcript"
        }
    },
    {
        "id": "4420105",
        "type": "transcript",
        "attributes": {
            "publishOn": "2021-04-20T15:06:05-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories' (ABT) CEO Robert Ford on Q1 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4420105-abbott-laboratories-abt-ceo-robert-ford-on-q1-2021-results-earnings-call-transcript"
        }
    },
    {
        "id": "4419986",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-04-20T08:50:46-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories 2021 Q1 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4419986-abbott-laboratories-2021-q1-results-earnings-call-presentation"
        }
    },
    {
        "id": "4419311",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-04-15T18:05:47-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems (CSII) Presents At 20th Annual Needham Healthcare Conference - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4419311-cardiovascular-systems-csii-presents-20th-annual-needham-healthcare-conference-slideshow"
        }
    },
    {
        "id": "4414567",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-03-17T13:56:16-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems (CSII) Presents At Oppenheimer 31st Annual Healthcare Conference - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4414567-cardiovascular-systems-csii-presents-oppenheimer-31st-annual-healthcare-conference-slideshow"
        }
    },
    {
        "id": "4411484",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-03-04T15:24:38-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems (CSII) Presents At Raymond James 42nd Annual Institutional Investors Conference - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4411484-cardiovascular-systems-csii-presents-raymond-james-42nd-annual-institutional-investors"
        }
    },
    {
        "id": "4410062",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-02-28T04:39:15-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems (CSII) Presents at SVB Leerink 10th Annual Global Healthcare Conference - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4410062-cardiovascular-systems-csii-presents-svb-leerink-10th-annual-global-healthcare-conference"
        }
    },
    {
        "id": "4403225",
        "type": "transcript",
        "attributes": {
            "publishOn": "2021-02-03T21:14:06-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems, Inc. (CSII) CEO Scott Ward on Q2 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4403225-cardiovascular-systems-inc-csii-ceo-scott-ward-on-q2-2021-results-earnings-call-transcript"
        }
    },
    {
        "id": "4401351",
        "type": "transcript",
        "attributes": {
            "publishOn": "2021-01-27T12:57:03-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories (ABT) CEO Robert Ford on Q4 2020 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4401351-abbott-laboratories-abt-ceo-robert-ford-on-q4-2020-results-earnings-call-transcript"
        }
    },
    {
        "id": "1790882",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-10-30T22:40:09-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems' CEO Discusses F1Q 2014 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1790882-cardiovascular-systems-ceo-discusses-f1q-2014-results-earnings-call-transcript"
        }
    },
    {
        "id": "1787112",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-10-30T16:40:00-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems, Inc. Discusses Q1 2013 Results (Webcast)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1787112-cardiovascular-systems-inc-discusses-q1-2013-results-webcast"
        }
    },
    {
        "id": "1748452",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-10-16T11:58:03-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott's CEO Discusses Q3 2013 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1748452-abbotts-ceo-discusses-q3-2013-results-earnings-call-transcript"
        }
    },
    {
        "id": "1717032",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-10-16T08:55:00-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Discusses Q3 2013 Results (Webcast)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1717032-abbott-laboratories-discusses-q3-2013-results-webcast"
        }
    },
    {
        "id": "1616192",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-08-07T20:53:01-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular's CEO Discusses F4Q 2013 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1616192-cardiovasculars-ceo-discusses-f4q-2013-results-earnings-call-transcript"
        }
    },
    {
        "id": "1553452",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-07-17T13:44:06-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories (ABT) CEO Discusses Q2 2013 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1553452-abbott-laboratories-abt-ceo-discusses-q2-2013-results-earnings-call-transcript"
        }
    },
    {
        "id": "1510852",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-06-19T14:40:03-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories' Management Presents at the Wells Fargo Securities Research & Economics 2013 Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1510852-abbott-laboratories-management-presents-at-the-wells-fargo-securities-research-and-economics-2013-healthcare-conference-transcript"
        }
    },
    {
        "id": "1495502",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-06-11T18:32:06-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories' Management Discusses at William Blair Growth Stock Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1495502-abbott-laboratories-management-discusses-at-william-blair-growth-stock-conference-transcript"
        }
    },
    {
        "id": "1469061",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-05-29T20:47:04-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories' Management Presents at Deutsche Bank 38th Annual Health Care Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1469061-abbott-laboratories-management-presents-at-deutsche-bank-38th-annual-health-care-conference-transcript"
        }
    },
    {
        "id": "1453161",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-05-22T09:56:13-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories' Management Presents at UBS Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1453161-abbott-laboratories-management-presents-at-ubs-global-healthcare-conference-transcript"
        }
    },
    {
        "id": "1392381",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-05-01T22:57:03-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular's CEO Discusses F3Q2013 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1392381-cardiovasculars-ceo-discusses-f3q2013-results-earnings-call-transcript"
        }
    },
    {
        "id": "1348121",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-04-17T13:16:02-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories' CEO Discusses Q1 2013 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1348121-abbott-laboratories-ceo-discusses-q1-2013-results-earnings-call-transcript"
        }
    },
    {
        "id": "1273441",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-03-14T10:15:03-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories' Management Presents at Barclays Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1273441-abbott-laboratories-management-presents-at-barclays-healthcare-conference-transcript"
        }
    },
    {
        "id": "1145311",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-01-30T21:29:05-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems' CEO Discusses F2Q13 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1145311-cardiovascular-systems-ceo-discusses-f2q13-results-earnings-call-transcript"
        }
    },
    {
        "id": "1127911",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-01-23T13:53:03-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories' CEO Discusses Q4 2012 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1127911-abbott-laboratories-ceo-discusses-q4-2012-results-earnings-call-transcript"
        }
    },
    {
        "id": "1001731",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-11-12T21:30:35-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories' Management Presents HCV Program Update (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1001731-abbott-laboratories-management-presents-hcv-program-update-transcript"
        }
    },
    {
        "id": "930191",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-10-17T13:50:12-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Management Discusses Q3 2012 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/930191-abbott-laboratories-management-discusses-q3-2012-results-earnings-call-transcript"
        }
    },
    {
        "id": "730061",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-07-18T14:30:08-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Management Discusses Q2 2012 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/730061-abbott-laboratories-management-discusses-q2-2012-results-earnings-call-transcript"
        }
    },
    {
        "id": "507861",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-04-18T15:20:07-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Management Discusses Q1 2012 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/507861-abbott-laboratories-management-discusses-q1-2012-results-earnings-call-transcript"
        }
    },
    {
        "id": "322061",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-01-25T14:50:18-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories' CEO Discusses Q4 2011 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/322061-abbott-laboratories-ceo-discusses-q4-2011-results-earnings-call-transcript"
        }
    },
    {
        "id": "300637",
        "type": "transcript",
        "attributes": {
            "publishOn": "2011-10-19T15:20:08-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories' CEO Discusses Q3 2011 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/300637-abbott-laboratories-ceo-discusses-q3-2011-results-earnings-call-transcript"
        }
    },
    {
        "id": "280539",
        "type": "transcript",
        "attributes": {
            "publishOn": "2011-07-20T14:20:08-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Management Discusses Q2 2011 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/280539-abbott-laboratories-management-discusses-q2-2011-results-earnings-call-transcript"
        }
    },
    {
        "id": "264579",
        "type": "transcript",
        "attributes": {
            "publishOn": "2011-04-20T16:50:29-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Management Discusses Q1 2011 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/264579-abbott-laboratories-management-discusses-q1-2011-results-earnings-call-transcript"
        }
    },
    {
        "id": "248886",
        "type": "transcript",
        "attributes": {
            "publishOn": "2011-01-26T19:05:13-05:00",
            "isLockedPro": false,
            "commentCount": 7,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories' CEO Discusses Q4 2010 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/248886-abbott-laboratories-ceo-discusses-q4-2010-results-earnings-call-transcript"
        }
    },
    {
        "id": "203235",
        "type": "transcript",
        "attributes": {
            "publishOn": "2010-05-05T21:52:08-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Cardiovascular Systems Inc. F3Q10 (Qtr End 03/31/10) Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/203235-cardiovascular-systems-inc-f3q10-qtr-end-03-31-10-earnings-call-transcript"
        }
    },
    {
        "id": "200016",
        "type": "transcript",
        "attributes": {
            "publishOn": "2010-04-21T15:19:10-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Q1 2010 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/200016-abbott-laboratories-q1-2010-earnings-call-transcript"
        }
    },
    {
        "id": "184875",
        "type": "transcript",
        "attributes": {
            "publishOn": "2010-01-27T16:48:27-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Q4 2009 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/184875-abbott-laboratories-q4-2009-earnings-call-transcript"
        }
    },
    {
        "id": "166543",
        "type": "transcript",
        "attributes": {
            "publishOn": "2009-10-14T16:04:00-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories, Q3 2009 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/166543-abbott-laboratories-q3-2009-earnings-call-transcript"
        }
    },
    {
        "id": "149067",
        "type": "transcript",
        "attributes": {
            "publishOn": "2009-07-15T16:20:51-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories, Q2 2009 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/149067-abbott-laboratories-q2-2009-earnings-call-transcript"
        }
    },
    {
        "id": "131529",
        "type": "transcript",
        "attributes": {
            "publishOn": "2009-04-17T22:18:19-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Q1 2009 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/131529-abbott-laboratories-q1-2009-earnings-call-transcript"
        }
    },
    {
        "id": "115760",
        "type": "transcript",
        "attributes": {
            "publishOn": "2009-01-21T16:07:12-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Q4 2008 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/115760-abbott-laboratories-q4-2008-earnings-call-transcript"
        }
    },
    {
        "id": "114415",
        "type": "transcript",
        "attributes": {
            "publishOn": "2009-01-12T16:13:14-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Acquisition of Advanced Medical Optics Announcement Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/114415-abbott-laboratories-acquisition-of-advanced-medical-optics-announcement-call-transcript"
        }
    },
    {
        "id": "100123",
        "type": "transcript",
        "attributes": {
            "publishOn": "2008-10-15T23:21:16-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Q3 2008 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/100123-abbott-laboratories-q3-2008-earnings-call-transcript"
        }
    },
    {
        "id": "85349",
        "type": "transcript",
        "attributes": {
            "publishOn": "2008-07-16T20:48:20-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Q2 2008 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/85349-abbott-laboratories-q2-2008-earnings-call-transcript"
        }
    },
    {
        "id": "72536",
        "type": "transcript",
        "attributes": {
            "publishOn": "2008-04-16T14:23:16-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Q1 2008 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/72536-abbott-laboratories-q1-2008-earnings-call-transcript"
        }
    },
    {
        "id": "61295",
        "type": "transcript",
        "attributes": {
            "publishOn": "2008-01-23T16:44:03-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Q4 2007 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/61295-abbott-laboratories-q4-2007-earnings-call-transcript"
        }
    },
    {
        "id": "50224",
        "type": "transcript",
        "attributes": {
            "publishOn": "2007-10-17T13:52:05-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Q3 2007 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/50224-abbott-laboratories-q3-2007-earnings-call-transcript"
        }
    },
    {
        "id": "49487",
        "type": "transcript",
        "attributes": {
            "publishOn": "2007-07-18T15:39:00-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Q2 2007 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/49487-abbott-laboratories-q2-2007-earnings-call-transcript"
        }
    },
    {
        "id": "41483",
        "type": "transcript",
        "attributes": {
            "publishOn": "2007-07-18T15:15:47-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Abbott Laboratories Q2 2007 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1200",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/41483-abbott-laboratories-q2-2007-earnings-call-transcript"
        }
    }
]